Clinical Trial Software Market is Segmented By Features of Software (EDC, eCOA/ePRO, eConsent), By Type of Deployment (On-cloud, On-premises). The rep....
Market Size in USD
CAGR14.3%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 14.3% |
Market Concentration | Medium |
Major Players | Advarra, Arisglobal, AssistRx, Calyx, Clario |
The clinical trial software market is estimated to be valued at USD 0.9 Bn in 2024 and is expected to reach USD 2.3 Bn by 2031, growing at a compound annual growth rate (CAGR) of 14.3% from 2024 to 2031. The increased investment in R&D by pharmaceutical companies and rising demand for improved data capture & clinical trial management systems is driving the growth of this market.
The clinical trial software market is expected to grow steadily during the forecast period. With advances in technology and pressure to increase efficiency, there is demand for clinical trial management systems that allow risk-based monitoring, remote monitoring techniques and use of telehealth for patient follow ups. This will help organizations streamline processes and decrease operational costs related to clinical trials.